Familial IPEX syndrome: Different glomerulopathy in two siblings

被引:21
作者
Park, Eujin [1 ]
Chang, Hye Jin [1 ]
Shin, Jae Il [2 ]
Lim, Beom Jin [3 ]
Jeong, Hyeon Joo [3 ]
Lee, Kyoung Bun [4 ]
Moon, Kyoung Chul [4 ,6 ]
Kang, Hee Gyung [1 ,5 ]
Ha, Il-Soo [1 ,6 ]
Cheong, Hae Il [1 ,5 ,6 ]
机构
[1] Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul 110744, South Korea
[2] Severance Childrens Hosp, Dept Pediat, Seoul, South Korea
[3] Severance Childrens Hosp, Dept Pathol, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea
[5] Seoul Natl Univ Hosp, Res Coordinat Ctr Rare Dis, Seoul 110744, South Korea
[6] Seoul Natl Univ, Med Res Ctr, Kidney Res Inst, Coll Med, Seoul 110744, South Korea
关键词
FOXP3; IPEX syndrome; membranous nephropathy; minimal change nephrotic syndrome; regulatory T cell; IMMUNE DYSREGULATION; POLYENDOCRINOPATHY; ENTEROPATHY; IMMUNODYSREGULATION; PATHOGENESIS;
D O I
10.1111/ped.12570
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome (OMIM 304790) is a rare hereditary disorder of the immune regulatory system caused by FOXP3 mutations. The clinical features of this syndrome include a wide spectrum of severe autoimmune diseases and renal involvement, mostly due to tubulointerstitial diseases, in some patients. Glomerulopathy of membranous nephropathy (MN) and minimal change nephrotic syndrome (MCNS), however, have also been reported. We encountered two children with IPEX syndrome from the same family. Interestingly, they had different glomerular lesions: one had MN and the other had MCNS. Herein we describe the cases of these siblings and review the possible mechanisms for the development of two different renal lesions.
引用
收藏
页码:e59 / e61
页数:3
相关论文
共 10 条
  • [1] T regulatory cell function in idiopathic minimal lesion nephrotic syndrome
    Araya, Carlos
    Diaz, Leila
    Wasserfall, Clive
    Atkinson, Mark
    Mu, Wei
    Johnson, Richard
    Garin, Eduardo
    [J]. PEDIATRIC NEPHROLOGY, 2009, 24 (09) : 1691 - 1698
  • [2] Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation
    Baud, O
    Goulet, O
    Canioni, D
    Le Deist, F
    Radford, I
    Rieu, D
    Dupuis-Girod, S
    Cerf-Bensussan, N
    Cavazzana-Calvo, M
    Brousse, N
    Fischer, A
    Casanova, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (23) : 1758 - 1762
  • [3] Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
    Hashimura, Yuya
    Nozu, Kandai
    Kanegane, Hirokazu
    Miyawaki, Toshio
    Hayakawa, Akira
    Yoshikawa, Norishige
    Nakanishi, Koichi
    Takemoto, Minoru
    Iijima, Kazumoto
    Matsuo, Masafumi
    [J]. PEDIATRIC NEPHROLOGY, 2009, 24 (06) : 1181 - 1186
  • [4] Control of regulatory T cell development by the transcription factor Foxp3
    Hori, S
    Nomura, T
    Sakaguchi, S
    [J]. SCIENCE, 2003, 299 (5609) : 1057 - 1061
  • [5] Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: an unusual cause of proteinuria in infancy
    Moudgil, Asha
    Perriello, Paige
    Loechelt, Brett
    Przygodzki, Ronald
    Fitzerald, Wendy
    Kamani, Naynesh
    [J]. PEDIATRIC NEPHROLOGY, 2007, 22 (10) : 1799 - 1802
  • [6] FOXP3 acts as a rheostat of the immune response
    Ochs, HD
    Ziegler, SF
    Torgerson, TR
    [J]. IMMUNOLOGICAL REVIEWS, 2005, 203 : 156 - 164
  • [7] Pathogenesis of membranous nephropathy: recent advances and future challenges
    Ronco, Pierre
    Debiec, Hanna
    [J]. NATURE REVIEWS NEPHROLOGY, 2012, 8 (04) : 203 - 213
  • [8] SHALHOUB RJ, 1974, LANCET, V2, P556
  • [9] IPEX as a result of Mutations in FOXP3
    van der Vliet, Hans J. J.
    Nieuwenhuis, Edward E.
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2007,
  • [10] Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome
    Wildin, RS
    Smyk-Pearson, S
    Filipovich, AH
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (08) : 537 - 545